Skip to content

Licensed Providers • HIPAA-Secure Telehealth • Discreet Cold-Chain Shipping

Start Consultation →
Vitercure Logo
🛒
4.8/5 · 3,127+ verified patient reviews
Medically reviewed · Dr. Jane Rote, MD
15.3% avg body weight
lost at 2.4mg
STEP-1 trial
68 wks phase 3 trial
duration
STEP-1 (N=1,961)
1 in 3 patients lost
20%+ body weight
STEP-1 trial
20% CV risk reduction
vs placebo
SELECT trial 2023
Wegovy semaglutide 2.4mg pre-filled weight loss injection pens
FDA-approved for chronic weight management
Once-weekly · Semaglutide 2.4mg max dose
WEIGHT LOSS INJECTION

Wegovy® (Semaglutide)
Buy Online for Weight Loss

Up to 15.3% body weight reduction — STEP-1 phase 3 trial data

Wegovy is a once-weekly semaglutide injection approved specifically for chronic weight management. In the landmark STEP-1 phase 3 trial (68 weeks, N=1,961), adults on 2.4mg semaglutide lost an average of 15.3% of their body weight compared to 2.6% with placebo — the highest FDA-approved semaglutide weight loss dose available. Wegovy is sourced through Vitercure's licensed US, UK and Canadian partner pharmacies.

All GLP-1 prescriptions on Vitercure are based on a clinical assessment. Your prescriber may recommend Wegovy, Ozempic®, Mounjaro® or another treatment depending on your health history and goals.

One-time Wegovy pen packs — No automatic subscription
Compare strengths, countries and pen counts in one place.

Transparent pricing from US, UK and Canada-sourced Wegovy pens. Your dose and refill plan are set by your prescriber.

Check if Wegovy is right for you View all GLP-1 options

Source Canada — 1mg

Select Wegovy pen strength and quantity. Your dose and titration schedule are confirmed by your licensed prescriber.

$599.59

One-time medication cost from this source pharmacy. Telehealth visit and labs may be billed separately.

Source United States — 2mg

Select Wegovy pen strength and quantity. Your dose and titration schedule are confirmed by your licensed prescriber.

$599.59

One-time medication cost from this source pharmacy. Telehealth visit and labs may be billed separately.

Source United States — 6.8mg

Select Wegovy pen strength and quantity. Your dose and titration schedule are confirmed by your licensed prescriber.

$599.59

One-time medication cost from this source pharmacy. Telehealth visit and labs may be billed separately.

Source United States — 9.6mg

Select Wegovy pen strength and quantity. Your dose and titration schedule are confirmed by your licensed prescriber.

$599.59

One-time medication cost from this source pharmacy. Telehealth visit and labs may be billed separately.

Source United Kingdom — 4mg

Select Wegovy pen strength and quantity. Your dose and titration schedule are confirmed by your licensed prescriber.

$599.59

One-time medication cost from this source pharmacy. Telehealth visit and labs may be billed separately.

Source United Kingdom — 1mg / 2mg / 4mg / 9.6mg

Select Wegovy pen strength and quantity. Your dose and titration schedule are confirmed by your licensed prescriber.

$599.79

One-time medication cost from this source pharmacy. Telehealth visit and labs may be billed separately.

Number of packs
Your information is HIPAA-compliant and 256-bit encrypted. A prescription is required.
Licensed US, UK & Canadian partner pharmacies
HIPAA-secure telehealth
Cold-chain temperature-controlled shipping

About Wegovy® (Semaglutide)

Wegovy contains semaglutide — the same active ingredient as Ozempic but at a higher, weight-management-focused dose of up to 2.4mg per week. It is FDA-approved for long-term weight management in adults with a BMI ≥30, or a BMI ≥27 with at least one weight-related condition such as high blood pressure, type 2 diabetes or high cholesterol. Wegovy is designed for ongoing use as part of a medically supervised program, not as a short-term diet pill.

When prescribed appropriately, semaglutide helps reduce appetite, slow stomach emptying and regulate satiety signals in the brain. The result is a meaningful reduction in daily caloric intake without the constant effort of strict dieting alone.

How Wegovy works

  • GLP-1 receptor activation: Semaglutide mimics the GLP-1 hormone, helping regulate appetite and blood sugar after meals.
  • Delayed gastric emptying: Food leaves the stomach more slowly, helping you feel full on smaller portions.
  • Central appetite regulation: Semaglutide acts on appetite centers in the hypothalamus, reducing cravings and emotional eating.
  • Cardiovascular protection: The SELECT 2023 trial showed Wegovy reduced major cardiovascular events by 20% vs placebo in adults with obesity and established CV disease.

Wegovy weight loss patient outcomes

Individual results vary. These are representative outcomes reported by patients. Consult your prescriber for personalized expectations.

MK

"Lost 41 lbs in 8 months. My blood pressure is normal for the first time in a decade. Wegovy changed my relationship with food."

−41 lbs · 8 months
RP

"37 lbs down since starting semaglutide. The appetite suppression is real — I'm genuinely not hungry the way I used to be."

−37 lbs · 6 months
SL

"I'd tried everything. 52 lbs gone in 10 months on Wegovy — BMI went from 36 to 27. Finally in a healthy range."

−52 lbs · 10 months

What Is Wegovy and How Is It Different from Other Semaglutide Products?

Wegovy is the brand name for semaglutide 2.4mg — a higher, weight-management-specific dose of the same GLP-1 hormone mimetic found in Ozempic. While Ozempic was developed for type 2 diabetes at doses up to 2mg, Wegovy delivers 2.4mg of semaglutide per week specifically to drive meaningful, sustained weight loss in people living with obesity or overweight. That extra 0.4mg produces meaningfully greater appetite suppression and weight loss outcomes in clinical trials.

Wegovy is also the only GLP-1 medication with large-scale cardiovascular outcomes data in a non-diabetes weight loss population. The 2023 SELECT trial found a 20% reduction in major adverse cardiovascular events — one of the most significant findings in obesity medicine in decades.

Who Qualifies for Wegovy? BMI and Eligibility Criteria

FDA approval for Wegovy (semaglutide 2.4mg) covers adults who meet one of the following criteria:

  • BMI ≥30 kg/m² (obesity) — regardless of other health conditions.
  • BMI ≥27 kg/m² (overweight) plus at least one weight-related condition such as type 2 diabetes, high blood pressure, high cholesterol, or obstructive sleep apnea.

Your prescriber will review your full medical history, current medications and lab work before determining whether Wegovy is safe and appropriate for you. Not all patients with these BMI values are automatically eligible — contraindications include a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia type 2 (MEN 2).

Wegovy vs Ozempic vs Mounjaro — Choosing the Right GLP-1 for Weight Loss

Three major injectable incretin therapies are now widely available for weight management. Your clinician will compare Wegovy, Ozempic and Mounjaro based on your specific health goals, medical history, insurance coverage and prior treatment response.

Medication Active ingredient Primary approval Typical use
Wegovy® Semaglutide (GLP-1) Chronic weight management Weight loss in adults with obesity/overweight + weight-related condition.
Ozempic® Semaglutide (GLP-1) Type 2 diabetes Diabetes management; off-label weight loss at lower doses.
Mounjaro® Tirzepatide (GIP/GLP-1) Type 2 diabetes; Zepbound for weight management Dual-action; highest average weight loss in phase 3 trials (22.5% at 15mg).

This comparison is educational only and does not replace medical advice. Indications, dosing and availability may vary by region.

Medically Reviewed

This medication content has been medically reviewed for clinical accuracy and patient safety. The information is for educational purposes and does not replace advice from your own healthcare provider.

Dr. Jane Rote, MD — Board-Certified Endocrinologist, Medical Reviewer

Dr. Jane Rote, MD

Board-Certified in Endocrinology & Metabolism

Last medical review: November 2025

Content reviewed for clinical accuracy

See if Wegovy is right for you

Answer a short questionnaire online. A licensed clinician will review your information and may prescribe Wegovy or another GLP-1 that fits your profile. No lengthy in-person visit required.

Get started — takes 5 minutes Call 1-479-765-1690

HIPAA-secure · Licensed US clinicians · No commitment required